PubRank

F Stockenhuber

Author PubWeight™ 24.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Folic acid supplementation improves erythropoietin response. Nephron 1995 2.40
2 Assessing coronary stenosis. Quantitative coronary angiography versus visual estimation from cine-film or pharmacological stress perfusion images. Eur Heart J 1996 2.18
3 Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Crit Care Med 1996 1.87
4 Energy metabolism in acute and chronic renal failure. Am J Clin Nutr 1990 1.60
5 Automated data acquisition by confocal laser scanning microscopy and image analysis of triple stained immunofluorescent leukocytes in tissue. J Immunol Methods 2000 1.10
6 Outcome prediction for patients with cirrhosis of the liver in a medical ICU: a comparison of the APACHE scores and liver-specific scoringsystems. Intensive Care Med 1996 1.02
7 Recombinant human erythropoietin and hematopoietic progenitor cells in vivo. Blood 1989 0.99
8 High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J Trauma 1998 0.97
9 Beneficial effect of renal transplantation on cognitive brain function. Kidney Int 1996 0.93
10 Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int 1990 0.92
11 Transient hyperoxaluria after ingestion of chocolate as a high risk factor for calcium oxalate calculi. Nephron 1989 0.91
12 Increased serum activity of interleukin-2 in patients with pre-eclampsia. J Autoimmun 1989 0.85
13 Increased plasma histamine levels in chronic renal failure. N Engl J Med 1987 0.84
14 Increased serum concentrations of adhesion molecules after coronary angioplasty. Clin Sci (Lond) 1994 0.82
15 Treatment of lymphoceles following renal transplantation. Transplant Proc 1990 0.81
16 Generation of the membrane attack complex during haemodialysis: impact of classical and alternative pathway components. Clin Sci (Lond) 1990 0.81
17 Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study). Transfusion 1996 0.79
18 [Probiotics for the prevention of antibiotic-induced diarrhea]. Z Gastroenterol 2012 0.79
19 Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure. Thromb Haemost 1988 0.78
20 Rapid screening for bacteriuria in pregnancy. Infection 1992 0.78
21 Recombinant human erythropoietin: a multipotential hemopoietic growth factor in vivo and in vitro. Contrib Nephrol 1990 0.76
22 Serial recording of sensory evoked potentials: a noninvasive prognostic indicator in fulminant liver failure. Hepatology 1994 0.76
23 Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin. BMJ 1990 0.75
24 Myocardial calcinosis associated with hemodialysis. Am J Cardiol 1987 0.75
25 Effect of conjugated estrogens on platelet function and prostacyclin generation in CRF. Kidney Int 1990 0.75
26 [Vascular kidney transplant rejection--is a duplex sonographic diagnosis possible?]. Rofo 1990 0.75
27 Potentiation of neurotoxic side effects by coadministration of imipenem to cyclosporine therapy in a kidney transplant recipient--synergism of side effects or drug interaction? Clin Nephrol 1986 0.75
28 Enhanced expression of a novel cytotoxicity-linked serine esterase by T lymphocytes during allograft rejection. Transplant Proc 1989 0.75
29 Post-transplantation malignant disease in patients with analgesic nephropathy. Lancet 1990 0.75
30 [Change in the patient profile in coronary heart disease at the time of initial evaluation with coronary angiography between 1975 and 1989]. Z Kardiol 1995 0.75
31 The use of recombinant human erythropoietin in lung transplantation. Wien Klin Wochenschr 1995 0.75
32 Serum concentrations of immune parameters during acute cardiogenic pulmonary edema. Crit Care Med 1992 0.75
33 Value of circulating immune parameters in renal transplantation. Transplant Proc 1997 0.75
34 [Cyclosporin therapy in minimal change nephritis]. Wien Klin Wochenschr 1987 0.75
35 Effect of calcium-channel blockers on renal function in renal-graft recipients treated with cyclosporine. N Engl J Med 1991 0.75
36 Comparison of Duplex sonography and color Doppler imaging in renal allograft evaluation: a prospective study. Eur J Radiol 1990 0.75
37 Does cyclosporin A affect neurotransmitters? Studies after kidney transplantation. Transplant Proc 1989 0.75
38 Successful outcome of a complicated pregnancy in a renal transplant recipient taking cyclosporine A. Clin Nephrol 1988 0.75
39 Comparison of CyA, OKT3, and ATG immunoprophylaxis in human liver transplantation. Transplant Proc 1991 0.75
40 Anemia and erythropoietin levels in lung transplant recipients. Transplantation 1995 0.75
41 ["Membrane attack complex" formation in hemodialysis treatment]. Wien Klin Wochenschr 1990 0.75
42 Value of serum soluble tumour necrosis factor concentrations in the diagnosis and prognosis of renal graft rejection. Nephrol Dial Transplant 1994 0.75
43 Serum interleukin 2 activity in renal graft recipients. Transplant Proc 1988 0.75
44 Serum-erythropoietin concentration during acute cardiogenic pulmonary edema. Angiology 1991 0.75